Prognostic value of glycated hemoglobin in colorectal cancer

Table 3 Receiver operating characteristics and Bayesian analysis of glycemic parameters

	Fasting blood glucose	Fasting insulin	HOMA-IR	HbA1c
AUC (SE)	0.657 (0.04)	0.728 (0.03)	0.738 (0.03)	0.860 (0.03)
95%CI	0.596-0.714	0.670-0.781	0.680-0.791	0.812-0.900
Criterion	97 mg/dL	12.5 μIU/mL	1.7%	5.4%
Sensitivity	42%	50%	81%	82%
Specificity	85%	84%	55%	82%
+LR (CI)	2.79 (1.63-5.06)	3.09 (1.87-5.41)	1.81 (1.43-2.30)	4.46 (2.96-7.06)
-LR (CI)	0.69 (0.61-0.81)	0.60 (0.52-0.72)	0. 35 (0.24-0.50)	0.22 (0.17-0.30)
P value1	0.0001	0.0001	0.0001	0.0001

¹Two-tailed Fisher Exact test. AUC: Area under the curve; +LR: Positive likelihood ratio; -LR: Negative likelihood ratio.